Aclarion, Inc., a healthcare technology enterprise based in San Mateo, California, was founded in 2008 and operates within the United States. The company specializes in creating software for magnetic resonance spectroscopy (MRS) applications. Its primary product is the NOCISCAN-LS Post-Processor suite, which features two key components: NOCICALC-LS, designed to analyze MRS data from discs to quantify degenerative pain biomarkers, and NOCIGRAM-LS, a software tool that assists in clinical decision-making. The company adopted its current name, Aclarion, Inc., in December 2021, having previously…
| Price | $2.55 |
|---|---|
| Market cap | $1.36M |
| Sector | Healthcare |
| Industry | Medical - Healthcare Information Services |
| Exchange | NASDAQ |
| 52-week range | 1.95-12.03 |
| Beta | 1.24 |
Explore ACON's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.